Literature DB >> 18328347

Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women.

Dona L Gray1, Kevin D O'Brien, David A D'Alessio, Bonnie J Brehm, Mark A Deeg.   

Abstract

Although circulating glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD), a minor high-density lipoprotein-associated protein, is elevated in patients with insulin resistance or high triglycerides, no information is available on the effect of weight loss or changes in insulin sensitivity on circulating GPI-PLD levels. The objective of the study was to determine the effect of weight loss and changes in insulin sensitivity on plasma GPI-PLD levels. Forty-two nondiabetic obese women were included in the study, which involved a 3-month dietary intervention randomizing patients to a low-fat or a low-carbohydrate diet. The study's main outcome measures were plasma GPI-PLD levels and insulin sensitivity as estimated by the homeostasis model assessment. The very low carbohydrate diet group lost more weight after 3 months (-7.6 +/- 3.2 vs -4.2 +/- 3.5 kg, P < .01), although the decrease in insulin resistance was similar between groups. Weight loss with either diet did not alter plasma GPI-PLD levels. However, baseline GPI-PLD levels correlated with the change in insulin sensitivity in response to the low-fat diet, whereas baseline insulin sensitivity correlated with the change in insulin sensitivity in response to the low-carbohydrate diet. Plasma GPI-PLD may serve as a clinical tool to determine the effect of a low-fat diet on insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18328347      PMCID: PMC3857163          DOI: 10.1016/j.metabol.2007.11.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  37 in total

1.  Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes.

Authors:  P Ebeling; A M Teppo; H A Koistinen; J Viikari; T Rönnemaa; M Nissén; S Bergkulla; P Salmela; J Saltevo; V A Koivisto
Journal:  Diabetologia       Date:  1999-12       Impact factor: 10.122

2.  Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion.

Authors:  Aldo V Greco; Gertrude Mingrone; Annalisa Giancaterini; Melania Manco; Manrico Morroni; Saverio Cinti; Marnie Granzotto; Roberto Vettor; Stefania Camastra; Ele Ferrannini
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

3.  A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women.

Authors:  Bonnie J Brehm; Randy J Seeley; Stephen R Daniels; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes.

Authors:  M A Deeg; R F Bowen; M D Williams; L K Olson; E A Kirk; R C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-07       Impact factor: 4.310

5.  Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study.

Authors:  B Vessby; M Uusitupa; K Hermansen; G Riccardi; A A Rivellese; L C Tapsell; C Nälsén; L Berglund; A Louheranta; B M Rasmussen; G D Calvert; A Maffetone; E Pedersen; I B Gustafsson; L H Storlien
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

6.  Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells.

Authors:  R F Bowen; N S Raikwar; L K Olson; M A Deeg
Journal:  Metabolism       Date:  2001-12       Impact factor: 8.694

7.  Statin therapy reduces serum levels of glycosylphosphatidylinositol-specific phospholipase D.

Authors:  Mark A Deeg; Nandita S Raikwar; Cynthia Johnson; Craig D Williams
Journal:  Transl Res       Date:  2007-05-25       Impact factor: 7.012

8.  Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes.

Authors:  Eeva Leinonen; Eva Hurt-Camejo; Olov Wiklund; Lillemor Mattson Hultén; Anne Hiukka; Marja-Riitta Taskinen
Journal:  Atherosclerosis       Date:  2003-02       Impact factor: 5.162

9.  Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  B Delia Johnson; Kevin E Kip; Oscar C Marroquin; Paul M Ridker; Sheryl F Kelsey; Leslee J Shaw; Carl J Pepine; Barry Sharaf; C Noel Bairey Merz; George Sopko; Marian B Olson; Steven E Reis
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

10.  Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D.

Authors:  Trisha A Kurtz; Naomi S Fineberg; Robert V Considine; Mark A Deeg
Journal:  Metabolism       Date:  2004-02       Impact factor: 8.694

View more
  5 in total

1.  Regularization Methods for High-Dimensional Instrumental Variables Regression With an Application to Genetical Genomics.

Authors:  Wei Lin; Rui Feng; Hongzhe Li
Journal:  J Am Stat Assoc       Date:  2015       Impact factor: 5.033

2.  Lipid droplets hypertrophy: a crucial determining factor in insulin regulation by adipocytes.

Authors:  Bahram Sanjabi; Monireh Dashty; Behiye Özcan; Vishtaseb Akbarkhanzadeh; Mehran Rahimi; Manlio Vinciguerra; Felix van Rooij; Saad Al-Lahham; Fareeba Sheedfar; Theo G van Kooten; C Arnold Spek; Ajda T Rowshani; Johannes van der Want; Rene Klaassen; Eric Sijbrands; Maikel P Peppelenbosch; Farhad Rezaee
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

3.  The Clinical Significance of Glycoprotein Phospholipase D Levels in Distinguishing Early Stage Latent Autoimmune Diabetes in Adults and Type 2 Diabetes.

Authors:  Wen Qin; Yu-Zhen Liang; Bao-Yu Qin; Jia-Li Zhang; Ning Xia
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

4.  Insulin-mimicking bioactivities of acylated inositol glycans in several mouse models of diabetes with or without obesity.

Authors:  Susumu Suzuki; Chitose Suzuki; Yoshinori Hinokio; Yasushi Ishigaki; Hideki Katagiri; Makoto Kanzaki; Viatcheslav N Azev; Nilanjana Chakraborty; Marc d'Alarcao
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

5.  Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to Cells In Vitro Depend on the (Pre-)Diabetic State in Rats and Humans.

Authors:  Günter A Müller; Andreas Lechner; Matthias H Tschöp; Timo D Müller
Journal:  Biomedicines       Date:  2021-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.